DRM has announced an expansion of its services to support brands and companies in newly legalized and evolving cannabis markets around the world.
As cannabis policies continue to change, markets across Europe, North America, Latin America, and Asia are opening regulatory doors for medical and adult-use cannabis production. Germany recently legalized adult-use cannabis at the national level while steadily expanding its medical framework, positioning the country as a key European market. Colombia has advanced medical cannabis distribution through pharmacies under a new decree, marking a significant evolution in Latin American regulation. Other markets, including Spain, Canada, Ukraine, and Thailand, are also evolving their medical cannabis laws and related policies, creating demand for compliant facility design.
© DRM
"Cannabis market reform is reshaping the landscape for regulated production and distribution globally," said Nic Bucholz, CEO at DRM. "Our expanded geographic focus and deep expertise in facility design, compliance, and international standards mean we can help clients navigate these complex regulatory environments and build facilities that meet stringent medical-grade requirements. With rapid advancements in technology over the past few years, we are looking forward to sharing the expertise to propel our clients far ahead of their current environment."
DRM's expanded services include regulatory-aligned design tailored to evolving international, national and regional cannabis regulations; Compliance consulting to support Good Manufacturing Practice (GMP) and Good Agricultural and Collection Practices (GACP) in preparation of facility certification readiness; Operational workflow optimization to align cultivation production with quality and safety requirements; International standard integration to help facilities succeed in global cannabis markets.
For more information:
DRM
https://drm.design/
